Questcor Finds Profits, at $28,000 a Vial

> it raised the price overnight, to more than $23,000 a vial, from $1,650, bringing the cost of a typical course of treatment for infantile spasms to above $100,000.

> we only have about 800 patients a year

> Sales ... totaled nearly $350 million in the first nine months this year, up 145 percent from the period a year earlier

The counter-intuitive lesson is that charging vastly higher prices don't necessarily hurt sales.